242 related articles for article (PubMed ID: 15173904)
1. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
[TBL] [Abstract][Full Text] [Related]
3. Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.
Stefaniak AB; Day GA; Hoover MD; Breysse PN; Scripsick RC
Toxicol In Vitro; 2006 Feb; 20(1):82-95. PubMed ID: 16061346
[TBL] [Abstract][Full Text] [Related]
4. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
5. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.
Stefaniak AB; Hoover MD; Dickerson RM; Peterson EJ; Day GA; Breysse PN; Kent MS; Scripsick RC
AIHA J (Fairfax, Va); 2003; 64(3):297-305. PubMed ID: 12809534
[TBL] [Abstract][Full Text] [Related]
6. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
[TBL] [Abstract][Full Text] [Related]
7. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
8. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
9. Exposure pathway assessment at a copper-beryllium alloy facility.
Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of beryllium exposure to small particles at a beryllium production facility.
Virji MA; Stefaniak AB; Day GA; Stanton ML; Kent MS; Kreiss K; Schuler CR
Ann Occup Hyg; 2011 Jan; 55(1):70-85. PubMed ID: 20805261
[TBL] [Abstract][Full Text] [Related]
11. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
12. Introduction to beryllium: uses, regulatory history, and disease.
Kolanz ME
Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
[TBL] [Abstract][Full Text] [Related]
13. Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.
Stefaniak AB; Virji MA; Day GA
Chemosphere; 2011 May; 83(8):1181-7. PubMed ID: 21251696
[TBL] [Abstract][Full Text] [Related]
14. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
15. Determination of the oxide layer thickness on beryllium metal particles.
Hoover MD; Castorina BT; Finch GL; Rothenberg SJ
Am Ind Hyg Assoc J; 1989 Oct; 50(10):550-3. PubMed ID: 2801503
[TBL] [Abstract][Full Text] [Related]
16. Differences in estimates of size distribution of beryllium powder materials using phase contrast microscopy, scanning electron microscopy, and liquid suspension counter techniques.
Stefaniak AB; Hoover MD; Dickerson RM; Day GA; Breysse PN; Scripsick RC
Part Fibre Toxicol; 2007 Feb; 4():3. PubMed ID: 17328812
[TBL] [Abstract][Full Text] [Related]
17. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
18. Identifying an apppropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives.
Paustenbach DJ; Madl AK; Greene JF
Appl Occup Environ Hyg; 2001 May; 16(5):527-38. PubMed ID: 11370933
[TBL] [Abstract][Full Text] [Related]
19. Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution.
Stefaniak AB; Guilmette RA; Day GA; Hoover MD; Breysse PN; Scripsick RC
Toxicol In Vitro; 2005 Feb; 19(1):123-34. PubMed ID: 15582363
[TBL] [Abstract][Full Text] [Related]
20. Beryllium contamination and exposure monitoring in an inhalation laboratory setting.
Muller C; Audusseau S; Salehi F; Truchon G; Chevalier G; Mazer B; Kennedy G; Zayed J
Toxicol Ind Health; 2010 Feb; 26(1):39-45. PubMed ID: 20056744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
